Key terms

About ABSI

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ABSI news

Mar 25 10:10pm ET Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), HilleVax, Inc (HLVX) and Cabaletta Bio (CABA) Mar 25 7:40am ET Analysts Are Bullish on Top Healthcare Stocks: CareCloud (CCLD), AbSci (ABSI) Mar 22 6:28am ET Buy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal Growth Mar 21 3:10pm ET Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbSci (ABSI) Mar 21 7:33am ET Absci expects cash to fund operations into 1H27 Mar 21 7:33am ET Absci reports Q4 EPS (25c), consensus (25c) Mar 05 4:27pm ET AbSci’s Strategic Financial Moves and Upcoming Catalysts Warrant a Buy Rating with $9 Price Target Mar 05 4:18pm ET Absci cash raise removes key share overhang, says Truist Feb 28 8:09pm ET Cathie Wood’s ARK Investment bought 2.99M shares of Absci today Feb 28 11:45am ET TD Cowen Keeps Their Buy Rating on AbSci (ABSI) Feb 28 5:58am ET Absci 16.7M share Spot Secondary priced at $4.50 Feb 27 4:05pm ET Absci files to sell $75M in common stock Feb 27 8:45am ET Largest borrow rate increases among liquid names Feb 21 7:36am ET Absci initiates IND-enabling studies for ABS-101 Jan 10 7:36am ET Absci appoints Sir Pangalos to its board of directors Jan 08 10:55am ET Buy Rating for AbSci’s Stock: Promising ABS-101 Data and Strategic Partnerships Drive Positive Outlook Jan 08 10:47am ET Absci price target raised to $7 from $4 at H.C. Wainwright Jan 08 7:28am ET Absci to present preclinical data for ABS-101

No recent press releases are available for ABSI

ABSI Financials

1-year income & revenue

Key terms

ABSI Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ABSI Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms